Stock REPRO-MED SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Repro-Med Systems, Inc. OTC Bulletin Board

Equities

US7599101026

Real-time Estimate Cboe BZX
Other stock markets
 15:29:06 10/05/2024 BST 		5-day change 1st Jan Change
2.235 USD +370.53% Intraday chart for Repro-Med Systems, Inc. +0.89% -9.20%
05-01 Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M MT
05-01 Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M
MT
Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
BU
KORU Medical Systems, Inc. reaffirms Financial Guidance for the Full Year of 2024
CI
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
BU
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
BU
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
BU
Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M
MT
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
BU
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024
CI
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
BU
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic
CI
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
BU
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin
CI
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. Stock
  5. News Repro-Med Systems, Inc.